LENZ Therapeutics, Inc. — 10-Q Filings
14 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by LENZ Therapeutics, Inc. (LENZ), sorted by most recent first. Each row links to the full filing on EdgarLookup. LENZ Therapeutics, Inc. has filed 14 10-Q documents with the SEC since 2021. To view all SEC filings by LENZ Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
3
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001815776-25-000071 | Nov 5, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0001815776-25-000056 | Jul 30, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0001815776-25-000032 | May 7, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0001815776-24-000071 | Nov 6, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0001815776-24-000060 | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0001815776-24-000042 | May 8, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-062942 | Nov 13, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-042525 | Aug 14, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-021242 | May 11, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-22-023869 | Nov 9, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-016869 | Aug 11, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0001564590-22-019862 | May 12, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0001564590-21-056184 | Nov 10, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-043980 | Aug 12, 2021 | Jun 30, 2021 |